ResearcherYonsei UniversityActive in the last 2 years
Munseok Choi
Matched on ORCID iD 0000-0002-9844-4747; OpenAlex author ID A5035893327. Sources: OpenAlex.
Their work
- Papers
- 12 (first author 4, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 39
2020: 4 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 4 papers
Papers 12
- Cardiovascular-Kidney-Metabolic Syndrome Severity and Risk of Pancreatic Cancer in a Large Prospective Cohort. Co-author DOI 10.1002/dmrr.70214↗
- Comparison of Long-Term Oncologic and Perioperative Outcomes of Minimally Invasive and Open Pancreatoduodenectomy for Resectable and Borderline Resectable Panc… Co-author DOI 10.1002/jhbp.70063↗
- International multicenter validation of an 18F-fluorodeoxyglucose positron emission tomography/computed tomography maximum standardized uptake value 4.0 thresh… Co-author DOI 10.1016/j.surg.2026.110503↗
- Minimally Invasive Pancreatoduodenectomy for Pancreatic Cancer: Current Perspectives and Future Directions. Co-author DOI 10.3390/cancers18020197↗
- Immediate Postoperative AbnobaVISCUM® F as an Adjuvant Treatment in Patients Receiving Standard Care after Pancreatic Cancer Resection. First author DOI 10.3349/ymj.2024.0493↗
- Development of a metabolite calculator for diagnosis of pancreatic cancer. Co-author DOI 10.1002/cam4.6233↗
- Systemic inflammation response index correlates with survival and predicts oncological outcome of resected pancreatic cancer following neoadjuvant chemotherapy. First author DOI 10.1016/j.pan.2022.08.009↗
- Laparoscopic pancreaticoduodenectomy in pancreatic ductal adenocarcinoma. Co-author DOI 10.7602/jmis.2021.24.3.169↗
- Laparoscopic repeated pancreatectomy for isolated local recurrence in remnant pancreas following laparoscopic radical pancreatectomy for pancreatic ductal aden… Co-author DOI 10.14701/ahbps.2020.24.4.542↗
- Neoadjuvant chemotherapy followed by total pancreatectomy with splenectomy and combined vascular resections after preoperative percutaneous transhepatic portal… First author DOI 10.14701/ahbps.2020.24.4.551↗
- Intraoperative Transfusion is Independently Associated with a Worse Prognosis in Resected Pancreatic Cancer-a Retrospective Cohort Analysis. First author DOI 10.3390/jcm9030689↗
- Repeated Pancreatectomy for Isolated Local Recurrence in the Remnant Pancreas Following Radical Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Pooled A… Co-author DOI 10.3390/jcm9123945↗
Closest collaborators
The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chang Moo Kang · 11 shared papers, 2020–2026 · strength 2.79
- Paper Minimally Invasive Pancreatoduodenectomy for Pancreatic Cancer: Current Perspectives and Future Directions. DOI 10.3390/cancers18020197↗
- Paper Cardiovascular-Kidney-Metabolic Syndrome Severity and Risk of Pancreatic Cancer in a Large Prospective Cohort. DOI 10.1002/dmrr.70214↗
- Paper Comparison of Long-Term Oncologic and Perioperative Outcomes of Minimally Invasive and Open Pancreatoduodenectomy for R… DOI 10.1002/jhbp.70063↗
- Ho Kyoung Hwang · 7 shared papers, 2020–2026 · strength 1.42
- Paper Comparison of Long-Term Oncologic and Perioperative Outcomes of Minimally Invasive and Open Pancreatoduodenectomy for R… DOI 10.1002/jhbp.70063↗
- Paper Immediate Postoperative AbnobaVISCUM® F as an Adjuvant Treatment in Patients Receiving Standard Care after Pancreatic C… DOI 10.3349/ymj.2024.0493↗
- Paper Systemic inflammation response index correlates with survival and predicts oncological outcome of resected pancreatic c… DOI 10.1016/j.pan.2022.08.009↗
- Sung Hyun Kim · 4 shared papers, 2021–2026 · strength 1.00
- Paper Comparison of Long-Term Oncologic and Perioperative Outcomes of Minimally Invasive and Open Pancreatoduodenectomy for R… DOI 10.1002/jhbp.70063↗
- Paper Immediate Postoperative AbnobaVISCUM® F as an Adjuvant Treatment in Patients Receiving Standard Care after Pancreatic C… DOI 10.3349/ymj.2024.0493↗
- Paper Systemic inflammation response index correlates with survival and predicts oncological outcome of resected pancreatic c… DOI 10.1016/j.pan.2022.08.009↗
- Seoung Yoon Rho · 4 shared papers, 2020–2026 · strength 0.95
- Paper Comparison of Long-Term Oncologic and Perioperative Outcomes of Minimally Invasive and Open Pancreatoduodenectomy for R… DOI 10.1002/jhbp.70063↗
- Paper Immediate Postoperative AbnobaVISCUM® F as an Adjuvant Treatment in Patients Receiving Standard Care after Pancreatic C… DOI 10.3349/ymj.2024.0493↗
- Paper Laparoscopic pancreaticoduodenectomy in pancreatic ductal adenocarcinoma. DOI 10.7602/jmis.2021.24.3.169↗
- Woo Jung Lee · 6 shared papers, 2020–2022 · strength 0.88
- Paper Systemic inflammation response index correlates with survival and predicts oncological outcome of resected pancreatic c… DOI 10.1016/j.pan.2022.08.009↗
- Paper Laparoscopic pancreaticoduodenectomy in pancreatic ductal adenocarcinoma. DOI 10.7602/jmis.2021.24.3.169↗
- Paper Repeated Pancreatectomy for Isolated Local Recurrence in the Remnant Pancreas Following Radical Pancreatectomy for Panc… DOI 10.3390/jcm9123945↗
- Seung Soo Hong · 2 shared papers, 2025–2026 · strength 0.66
- Paper Comparison of Long-Term Oncologic and Perioperative Outcomes of Minimally Invasive and Open Pancreatoduodenectomy for R… DOI 10.1002/jhbp.70063↗
- Paper Immediate Postoperative AbnobaVISCUM® F as an Adjuvant Treatment in Patients Receiving Standard Care after Pancreatic C… DOI 10.3349/ymj.2024.0493↗
- Isamu Makino · 1 shared paper, 2026 · strength 0.19
- Atsushi Tomioka · 1 shared paper, 2026 · strength 0.19
- Teiichi Sugiura · 1 shared paper, 2026 · strength 0.19
- Shintaro Yagi · 1 shared paper, 2026 · strength 0.19
- Yoo‐Seok Yoon · 1 shared paper, 2026 · strength 0.19
- Tetsuya Idichi · 1 shared paper, 2026 · strength 0.19
- Kousei Ishigami · 1 shared paper, 2026 · strength 0.19
- Hongbeom Kim · 1 shared paper, 2026 · strength 0.19
- Hyung Il Seo · 1 shared paper, 2026 · strength 0.19
- Shigeru Marubashi · 1 shared paper, 2026 · strength 0.19
- Naru Kim · 1 shared paper, 2026 · strength 0.19
- Minoru Oshima · 1 shared paper, 2026 · strength 0.19
- Masayuki Tanaka · 1 shared paper, 2026 · strength 0.19
- Katsuhisa Ohgi · 1 shared paper, 2026 · strength 0.19
- Yoon Soo Chae · 1 shared paper, 2026 · strength 0.19
- Etsuro Hatano · 1 shared paper, 2026 · strength 0.19
- Shingo Baba · 1 shared paper, 2026 · strength 0.19
- Naoki Ikenaga · 1 shared paper, 2026 · strength 0.19
- Satoshi Hirano · 1 shared paper, 2026 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.